**Research-use only.** This product is an investigational reference standard supplied by Coastal Vanguard LLC for laboratory research, in-vitro investigation, analytical-method development, and preclinical animal-model research conducted by qualified researchers. It is not a medication, is not approved by the U.S. Food and Drug Administration, the European Medicines Agency, or any other regulatory authority for human or veterinary administration, and is supplied strictly under a research-use-only label.
**Dose tiers:** 50 mg or 100 mg finished liquid vial. Pre-mixed multi-dose glass vial supplied for research protocols that require a defined finished injectable formulation. GHK-Cu is supplied as a research reference standard for in-vitro copper-binding studies, tissue-culture assays, and analytical-method development.
For topical research, see the GHK-Cu Topical listing in the Topical & Nasal section.
**What this product is:** A research-grade peptide reference standard sealed under inert atmosphere with a lot-specific Certificate of Analysis.
**What this product is not:** A medication, a supplement, a diagnostic, a treatment, or a therapeutic for any human or veterinary condition. It is not intended for administration to humans or animals.
**Intended use:** Laboratory research, in-vitro assays, analytical-method development (HPLC, mass spectrometry), receptor-binding studies, and preclinical animal-model research conducted under appropriate institutional oversight.
**Storage and handling:** Store the lyophilized powder at −20 °C (long-term) or 2–8 °C (short-term). Reconstitute only with the solvent appropriate to the downstream research protocol. Refer to the Certificate of Analysis for lot-specific purity, residual solvent, and endotoxin data.